Given that LD accumulation in our experimental setting occurred through the GSK3β-PPARα signaling axis downstream of PIM1, we hypothesized that blocking PPARα could counteract the known positive effect of PIM1 induction on cell proliferation in prostate cancer. The gene discussed is GSK3B; the disease is prostate carcinoma.